[Ip-health] FT (The Big Read) - Intellectual Property: Big Tech vs Big Pharma: the battle over US patent protection

Thiru Balasubramaniam thiru at keionline.org
Mon Oct 16 07:18:29 PDT 2017


The Big Read Intellectual property  Add to myFT
Big Tech vs Big Pharma: the battle over US patent protection

Critics fear Silicon Valley lobbying has weakened the defence of
intellectual property and sapped innovation

Rana Foroohar in New York

Sherry Knowles has a very personal interest in defending intellectual
property — she believes it saved her life. Ms Knowles, herself a patent
lawyer, fears that the treatment that helped her combat breast cancer, a
medicine known as Adriamycin, would not have been produced if the tighter
patent regulations introduced over the past decade had been in place when
she fell ill.

As a former chief patent counsel at GlaxoSmithKline, Ms Knowles, who runs
her own life sciences legal consulting firm, has a vested interest in
defending IP laws. She knows that major pharmaceutical groups like GSK can
only monetise new drugs based on their ability to patent innovations.

But pointing to Supreme Court rulings that have made innovations in drugs
difficult to patent, and to changes in the patent adjudication system, she
says it has become tougher for some groups to protect their interests.

“If companies can’t defend their intellectual property, they won’t invest,”
says Ms Knowles. “It’s that simple.”

Few will have too much sympathy for Big Pharma. The industry has long been
in the line of fire over drug pricing and its monopolistic power. But the
large drug companies are only one voice among many that have begun to
complain about how shifts in the US patent system over the past decade have
weakened the ability of companies to protect their innovations.

Start-up biotech firms are complaining, as are a number of semiconductor
and electronics firms, clean-tech companies, data analysis groups,
universities and innovators working on the “internet of things” — not to
mention the venture capitalists that invest in them.

Indeed, the only ones that seem not to be complaining about the current
system are a handful of the biggest Silicon Valley companies — including
Google, Apple, Intel and Cisco. While they all have their own patents to
protect, their business models, which involve products that include
hundreds or even thousands of bits of IP, tend to do better when there are
fewer patents to deal with.

But small and mid-sized software and hardware suppliers as well as life
sciences companies have very different business models — ones that live or
die on the ability to protect a handful of patents, and thus monetise their
years of investment.

For many of these companies, the shifts in the system that began a decade
ago have gone too far.

Thanks to a series of court rulings since the mid-2000s, such as eBay v
MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories
in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent passing of
the American Invents Act under President Barack Obama in 2011, patents in
the US have become harder to secure — and harder to defend.

There are numerous metrics that reflect this, but one simple measure is
that the US has moved from first to 10th place globally in terms of patent
protection, according to a yearly study by the US Chamber of Commerce,
based on research by the Israeli data analysis group Pugatch Consilium.
While the study shows the US is still strong on other aspects of IP
creation, the patent system itself is now tied with Hungary in terms of the
strength of patent rights.

Perhaps as a result, many companies complain of “efficient infringement” on
the part of larger rivals, which simply copy or take the IP they want, then
settle with aggrieved parties out of court for less than the full value of
the IP.

Few companies except those who have been in open litigation will go on the
record with their travails, for fear of being blackballed within the tech
community. Among those that do, there are numerous stories of patent fights
that border on the absurd: consider Zond, a Massachusetts-based
manufacturer of plasma generators whose IP has been challenged nearly 400
times, unsuccessfully, by companies including Intel, Gillette, AMD and

Why did the US patent system, which was written into the constitution as a
key right and had successfully fostered American IP development since its
last tweak in 1952, undergo such a radical shift? In a word: trolls — which
is the industry nickname for companies that issue a flurry of spurious
patent filings. Or perhaps more accurately, the patent troll narrative.

When the dotcom bubble burst in the early 2000s, many companies were left
with nothing of value except their patents, which were then bought up by
financial companies or larger tech entities that tried to milk some cash
from them.

At the same time, the software suppliers that served the burgeoning
commercial internet and smartphone markets began to broaden. The majority
of those companies had legitimate technologies and ideas to protect. But
some “patent trolls” were playing a game of legal arbitrage, filing as many
patents as possible to get larger companies to settle with them for the use
of their technology.

US innovation has always been dogged by patent trolls. But by the time that
Mr Obama took office in 2009, the patent troll narrative had reached a new
fever pitch. It was a storyline supported by many Big Tech companies which
individually and via lobbying bodies pushed for the American Invents Act.

The law established a non-court adjudication body, the Patent Trial and
Appeal Board. The idea was to save time and money with the non-court
“inter-parties” process, and indeed, patent claims went from taking three
years and an average cost of $2m to settle, to being done with $200,000 in
18 months.

Yet the largest tech groups, particularly Google (which declined to comment
for this story) lobbied hard for even more anti-patent legislation in 2013.
Companies which supported additional legislation say it would have cut out
legal distortions around issues like the venue in which patent cases are
heard, thereby cutting litigation costs.

“It was shocking to see calls from some in the tech industry for a second
round of drastic patent legislation immediately after all we did in the
AIA, and before the AIA had even gone into effect,” says David Kappos,
former head of the US Patent and Trademark Office, now with lawyers
Cravath, Swaine & Moore, who says the argument about patent trolls
“increasingly rang false”.

Mr Kappos represents Qualcomm, one of the critics of the current system,
but both he and the legal firm also represent clients on the other side of
the argument.

“Ultimately, the real agenda sunk in,” he says. “This second round of
drastic cutbacks to the patent system was a commercial ploy designed not to
stop abuse but to cut supply chain costs by devaluing others’ innovation.”

The push for new legislation was ultimately held up in Congress. Meanwhile,
Michelle Lee, Google’s former head of IP, replaced Mr Kappos as head of the
USPTO. In 2013, the White House put out an alarming report on the
prevalence of patent trolls and their destructive effects, blaming them for
two-thirds of patent suits.

Yet subsequent research done by the non-partisan Governmental Accounting
Office put that number at one-fifth, and other data showed that the number
of patent defendants had been roughly flat before and after the AIA. (Ms
Lee, who resigned from the patent office in June, could not be reached for

“The historical trend in litigation rates relative to patents granted
clearly does not support claims that litigation in the past decades has
‘exploded’ above the long-term norm,” wrote Bowdoin College professor
Zorina Khan, in a 2013 paper “Trolls and Other Patent Inventions”.

What’s more, she argued, a number of legislative changes seemed to address
“the ephemeral demands of the most strident interest groups at a single
point in time” and are “inconsistent with the fundamentals of the US
intellectual property system”.

Indeed, some would argue that the system of adjudication for patents
introduced under the Obama administration has become a “powerful shield”
for those accused of patent infringement. Most of the verdicts go against
the patent holder, leading former chief judge Randall Rader, who led the
court in charge of patent appeals, to label it the “death squad” for IP.

Another retired federal district court judge, Paul Michel, has become a
vocal opponent of the system, arguing that excessive invalidations and the
way in which the adjudication board has pre-empted court rulings are
sapping both the strength of the patent system, and American innovation

“The cumulative [anti-patent] effect of the Supreme Court rulings and the
AIA was, together, stronger than it should have been,” he says, in part
because of what he and others say was lobbying on the part of large tech
firms. “Patent values are plummeting, and licensing and capital investments
in many technologies are sinking. The AIA has done more harm than good.”

There are those who say there’s not much to fix in the system. Mark
Chandler, the general counsel of Cisco, recently had two patents overturned
in the PTAB system, but still believes it is the best way to determine
patent worthiness.

“The patent right is designed to promote progress through the reward of a
legal monopoly. The system is effective as long as patents represent a
true, implementable technology, and patents which never should have been
granted can be efficiently eliminated from the system. If the system cannot
achieve this, it puts a deadweight burden on the economy by blocking
innovation by others and unnecessarily driving up prices to consumers.”
Companies such as Intel would say much the same thing.

The key is deciding which patents should be granted — and opinions between
Big Tech and many other innovators differ wildly.

President Barack Obama visits a school robotics lab as part of a day of
events marking the signature of the America Invents Act in 2011 © Getty
“You need a patent system that induces the right behaviour, which means one
in which incumbents have to pay for innovations, not copy or steal them,”
says venture capitalist Gary Lauder, a Silicon Valley-based investor who
has poured more than half a billion dollars in funding into nearly 100
companies and 60 venture capital funds in the past 28 years, and has become
an advocate for a stronger patent system.

“We need to protect the larger start-up ecosystem, which is where the
majority of jobs are created,” he says. “It’s an issue that’s really
crucial for our economy. Today the incumbents are copying the innovators.
Next both will be copied and displaced by cheap foreign knock-offs.”

There is little doubt that strong IP protection is linked to stronger
economic growth. A recent paper from the National Bureau of Economic
Research found that holding a patent (and being able to defend it)
increases the probability of securing venture capital funding by 53 per
cent, start-up job growth by 36 per cent and start-up sales by 51 per cent.
Another paper, “Patents and the Wealth of Nations” by Stanford academic
Stephen Haber, found that countries that protect patents enjoy stronger
economic growth. His research also shows that the patent troll narrative,
and the idea that litigious patent holders can “hold up” innovation for
bigger groups, is inconsistent with the data.

As both sides debate the data, the next battle in the patent wars is
getting under way. Lawmakers like Democratic Senator Chris Coons are now
pushing for new rules that would strengthen patent laws, amid worries that
the US is beginning to lose important innovations to Europe and China,
which despite its own reputation for theft of foreign IP has been
strengthening patent protection.

There are separate debates over whether software and biotech’s different
business models might require two patent systems. Next year, the Supreme
Court may hear a case, Oil States vs Greene’s Energy, that will challenge
the entire constitutionality of the current patent system. Either way,
innovators and investors will go where they can for the best IP protection.
The patent wars will play a large role in what part of the world that will
be — and where the next life-saving drug will be developed.

Role of trolls overstated in White House numbers

There is an abundance of data that both advocates and critics of the
current patent system spin in all sorts of ways to make their case.

In 2013, then president Barack Obama issued a report saying that patent
lawsuits were rising, and two-thirds of all patent suits were brought by
trolls. But that report was itself influenced by the Big Tech narrative on
patent trolls — Google was the number one corporate visitor to the White
House in the second term of the Obama administration.

The White House report didn’t account for the fact that the America Invents
Act itself artificially jacked up the number of cases by changing rules to
disallow plaintiffs from suing multiple defendants in a single suit, thus
necessitating that the number of suits equal the number of defendants.

A couple of months later, the non-partisan Government Accounting Office
issued a report saying that patent trolls were responsible for only
one-fifth of the lawsuit problem.

If you look at the issue using data from Lex Machina that charts lawsuits
based on individual defendants — the best way to compare figures before and
after the AIA — you realise that the number of patent lawsuits was just
about steady before and after the troll narrative took hold. The brief
spike at the end of 2011 was related to a filing deadline before the AIA
kicked in.

The conclusion? Trolls have been overblown as a patent issue.

Thiru Balasubramaniam
Geneva Representative
Knowledge Ecology International
41 22 791 6727
thiru at keionline.org

More information about the Ip-health mailing list